RPG Life Sciences Limited (IN:RPGLIFE)
:RPGLIFE
Want to see IN:RPGLIFE full AI Analyst Report?
RPGLIFE Stock Chart & Stats
₹2303.55
-₹26.05(-1.12%)
At close: 4:00 PM EST
₹2303.55
-₹26.05(-1.12%)
Day’s Range― - ―
52-Week Range₹1,731.25 - ₹2,715.90
Previous CloseN/A
Volume11.08K
Average Volume (3M)3.23K
Market Cap
₹40.09B
Enterprise Value₹38.66B
Total Cash (Recent Filing)₹2.24B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)43.4
Beta0.74
Next Earnings
Jul 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.85%
Share Statistics
EPS (TTM)130.26
Shares Outstanding16,539,015
10 Day Avg. Volume8,652
30 Day Avg. Volume3,228
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)7.03
Price to Sales (P/S)5.71
P/FCF Ratio89.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetNear-zero leverage materially reduces refinancing and interest-rate risk, giving management flexibility to fund growth or absorb shocks. Substantial equity build-up and rising ROE (~35%) indicate efficient capital deployment and a stronger capital base to support durable investments.
High And Expanding MarginsConsistently high gross margins and a large net-margin expansion imply pricing power and operating leverage within its branded formulations business. Sustained margin strength supports long-term profitability and internal cash generation even if top-line growth moderates.
Sustained Revenue GrowthMaterial multi-year organic revenue gains reflect effective commercial execution and product adoption in core therapy areas. Persistent top-line expansion supports scale benefits, margin sustainability, and a larger base for reinvestment over the medium term.
Bears Say
Mixed Cash-flow ConversionEarnings have outpaced cash generation, with operating cash and FCF covering a minority of reported net income. Persistent or recurring gaps reduce available internal funding for capex, acquisitions, or dividends and increase reliance on working-capital management.
FY2025 Step-up Sustainability RiskA marked one‑year jump in earnings and margins can reflect transient factors. If FY2025 is an outlier, future periods may revert closer to historical trends, complicating forecasting, capital-allocation decisions, and expectations for durable cash generation.
Domestic Market ConcentrationHeavy dependence on the Indian prescription market concentrates exposure to local pricing, regulatory shifts, and competitive dynamics. Limited clarity on export scale reduces geographic diversification that could otherwise buffer domestic cyclicality or policy-driven revenue volatility.
RPG Life Sciences Limited News
RPGLIFE FAQ
What was RPG Life Sciences Limited’s price range in the past 12 months?
RPG Life Sciences Limited lowest stock price was ₹1731.25 and its highest was ₹2715.90 in the past 12 months.
What is RPG Life Sciences Limited’s market cap?
RPG Life Sciences Limited’s market cap is ₹40.09B.
When is RPG Life Sciences Limited’s upcoming earnings report date?
RPG Life Sciences Limited’s upcoming earnings report date is Jul 24, 2026 which is in 79 days.
How were RPG Life Sciences Limited’s earnings last quarter?
RPG Life Sciences Limited released its earnings results on Apr 29, 2026. The company reported ₹18.08 earnings per share for the quarter, beating the consensus estimate of N/A by ₹18.08.
Is RPG Life Sciences Limited overvalued?
According to Wall Street analysts RPG Life Sciences Limited’s price is currently Overvalued.
Does RPG Life Sciences Limited pay dividends?
RPG Life Sciences Limited pays a Notavailable dividend of ₹20 which represents an annual dividend yield of 0.85%. See more information on RPG Life Sciences Limited dividends here
What is RPG Life Sciences Limited’s EPS estimate?
RPG Life Sciences Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RPG Life Sciences Limited have?
RPG Life Sciences Limited has 16,539,015 shares outstanding.
What happened to RPG Life Sciences Limited’s price movement after its last earnings report?
RPG Life Sciences Limited reported an EPS of ₹18.08 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.761%.
Which hedge fund is a major shareholder of RPG Life Sciences Limited?
Currently, no hedge funds are holding shares in IN:RPGLIFE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It also provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies, such as nephrology, rheumatology, oncology, gastroenterology, cardiovascular, diabetology, orthopedics, neuropsychiatry, respiratory, nutritional, general, urology, anti-diabetic, anti-dengue, vitamins and minerals, gynecology and pediatrics, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
Technical Analysis
Aarti Drugs Limited
―
Gufic Biosciences Limited
―
Morepen Laboratories Limited
―
Orchid Pharma Limited
―
Unichem Laboratories Limited
―